Rapafusyn Pharmaceuticals
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
855 N Wolfe St Ste B, Baltimore, Marylan...Phone Number
(410) 995-8234Website
www.rapafusyn.comRevenue
$6.4 MillionIndustry
About Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals is a pioneering biotechnology company focusing on the development of RapaGlues, innovative non-degrading molecular glues that target otherwise intractable proteins. Their platform is designed to inhibit a wide range of intracellular and transmembrane targets, making them suitable for various therapeutic areas, including oncology, immunology, and acute kidney injury. The company's lead candidate, RAP-0001, is a selective ENT1 inhibitor aimed at protecting renal function during cardiac surgery. Rapafusyn is actively seeking partnerships to accelerate the development of its groundbreaking therapies.Explore more
Rapafusyn Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Rapafusyn Pharmaceuticals
Compare insights from companies similar to Rapafusyn Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Rapafusyn Pharmaceuticals Tech Stack
A closer look at the technologies used by Rapafusyn Pharmaceuticals
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Rapafusyn Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Rapafusyn Pharmaceuticals is a pioneering biotechnology company focusing on the development of RapaGlues, innovative non-degrading molecular glues that target otherwise intractable proteins. Their platform is designed to inhibit a wide range of intracellular and transmembrane targets, making them suitable for various therapeutic areas, including on... Read More
